Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon a-2a Plus Ribavirin in HIV/HCV Co-infected Patients Failing Previous Interferon Therapy
NCT00215839Phase 3Unknown
- Sponsor
- Hepatitis Resource Network
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2a in hepatitis C (HCV), sponsored by Hepatitis Resource Network. Status: unknown.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00215839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215839.